Top Stories
-
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Topic
-
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Topic
-
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Topic
-
On Sunday, Oct. 6, cancer survivors, researchers, and physicians will cycle through the Hudson Valley to help Columbia solve cancer.
Topic
Latest News
- June 20, 2018
Columbia researchers discover that DNA repair falters when cells can’t move damaged DNA to repair centers within the nucleus. The results could lead to better cancer treatments.
- June 19, 2018
Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
Topic
- June 6, 2018
Cachexia, the debilitating muscle wasting that occurs in late-stage cancer patients, may be due to an overload of zinc in muscles, finds a new study.
Topic
-
Source:
Washington PostJune 4, 2018Topic
- June 4, 2018
Joint pain relief from omega-3s may help more women adhere to hormonal breast cancer treatment, a study suggests.
Topic
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
Topic
- April 10, 2018
A new Science study from Columbia stem cell researchers has found that the liver is the surprising source of a growth factor that keeps bone marrow stem cells healthy.
Topic
- April 5, 2018
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
Topic
- March 30, 2018
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
Topic
- February 28, 2018
Pathology’s new recruit, Kevin Gardner, talks about health disparities and the need for more diversity among research participants.
Topic
